Lung infection with multi-drug resistant
Conditions
Interventions
Trial A treatment group :Oral administration of Qiguiyin Decoction
Trial B treatment group:Oral administration of Qiguiyin Decoction
Trial A control group:Conventional treatment
Trial B control group:Conventional treatment
Sponsors
Tongzhi Campus, Dongzhimen Hospital, Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients aged 18-80 years; 2. Patients with no indications of respiratory tract infection but multi-drug resistant microorganisms or multi-drug resistant microorganisms with lung infection detected in the lower respiratory tract; 3. TCM dialectics meets the diagnostic criteria of Qi deficiency; 4. Agree to participate in the project.
Exclusion criteria
Exclusion criteria: 1. Infections in other parts: abdominal cavity infection, urinary tract infection, skin infection, intracranial infection; 2. Those infected with A or B virus; 3. Those infected with Mycobacterium tuberculosis; 4. Patients with fasting water for various reasons; 5. Patients with liver and kidney insufficiency; 6. Patients with immune system diseases; 7. Oral and respiratory mucosa Injury patients; 8. Patients without artificial airways and unable to cooperate with the coughing up of lower respiratory secretions; 9. Body mass index 30.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| White blood cell count;Percentage of neutrophils;c-reactive protein;Procalcitonin level;Sputum culture results;Drug susceptibility test of multi-drug resistant bacteria; | — |
Countries
China
Contacts
Public ContactZhang Qing
Tongzhi Campus, Dongzhimen Hospital, Beijing University of Chinese Medicine
Outcome results
None listed